{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:16:37Z","timestamp":1788419797446,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (MRSA) remains a clinically important pathogen, and bacterial efflux systems can reduce intracellular antibiotic accumulation and compromise antibacterial efficacy. NorA, a well-studied multidrug efflux pump in\n                    <jats:italic>S. aureus<\/jats:italic>\n                    , is associated with the efflux of fluoroquinolones and fluorescent substrates such as ethidium bromide (EtBr), making it a potential target for antibiotic adjuvant discovery. In this study, 100 PubChem-identifiable\n                    <jats:italic>Forsythia suspensa (F. suspensa)<\/jats:italic>\n                    -derived small molecules were screened against NorA using CB-Dock2 with AutoDock Vina scoring. Amentoflavone (AME), a naturally occurring biflavonoid, was identified as the top-ranked candidate and displayed a predicted binding pose within the NorA transmembrane cavity, with multiple potential interactions involving residues such as Thr336, Arg310, and Ser133. Molecular dynamics simulation performed using GROMACS 2025.4 further supported the dynamic stability of the predicted AME-NorA complex in a membrane-embedded environment. Functionally, AME increased intracellular EtBr-associated fluorescence in MRSA, suggesting altered EtBr-associated intracellular accumulation or efflux-associated activity. Although AME alone showed no evident direct anti-MRSA activity at concentrations up to 512 \u03bcg\/mL, its combination with ciprofloxacin enhanced ciprofloxacin-mediated inhibition and killing of MRSA. Specifically, AME reduced the minimum inhibitory concentration (MIC) of ciprofloxacin from 1 to 0.5 \u03bcg\/mL and the minimum bactericidal concentration (MBC) from 2 to 1 \u03bcg\/mL. These findings suggest that AME may serve as a\n                    <jats:italic>F. suspensa<\/jats:italic>\n                    -derived ciprofloxacin-potentiating candidate against MRSA, potentially associated with altered efflux-related activity. Further studies using NorA genetic models, membrane permeability assays, intracellular ciprofloxacin accumulation assays, and multiple clinical isolates are needed to clarify the target specificity and broader applicability of AME-mediated ciprofloxacin potentiation.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1919329","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:43:55Z","timestamp":1788417835000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening of Forsythia suspensa-derived compounds identifies amentoflavone as a ciprofloxacin-potentiating candidate against MRSA"],"prefix":"10.3389","volume":"17","author":[{"given":"Yu","family":"Fang","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Yue","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhong","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangsheng","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanzhu","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16483","DOI":"10.1038\/s41598-024-65991-5","article-title":"Thymoquinone' potent impairment of multidrug-resistant Staphylococcus aureus NorA efflux pump activity","volume":"14","author":"Ahmad","year":"2024","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e202500227","DOI":"10.1002\/open.202500227","article-title":"Lupeol as a potential inhibitor of NorA efflux pumps in Staphylococcus aureus: in silico and in vitro evidence","volume":"14","author":"Ara\u00fajo","year":"2025","journal-title":"Chemistry Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41589-022-00994-9","article-title":"Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus","volume":"18","author":"Brawley","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1002\/ardp.70000","article-title":"NorA efflux pump inhibitors: expanding SAR knowledge of pyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide derivatives","volume":"358","author":"Cernicchi","year":"2025","journal-title":"Arch. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e04876","DOI":"10.1128\/spectrum.04876-22","article-title":"Efflux pump inhibitory potential of indole derivatives as an arsenal against NorA-overexpressing Staphylococcus aureus","volume":"11","author":"Chandal","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"107504","DOI":"10.1016\/j.micpath.2025.107504","article-title":"Naringenin as potentiator of norfloxacin efficacy through inhibition of the NorA efflux pump in Staphylococcus aureus","volume":"203","author":"de Menezes Dantas","year":"2025","journal-title":"Microb. Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10863-021-09906-3","article-title":"Effect of carvacrol and thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains","volume":"53","author":"dos Santos Barbosa","year":"2021","journal-title":"J. Bioenerg. Biomembr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dks005","article-title":"Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees","volume":"67","author":"Holler","year":"","journal-title":"J. Antimicrob. Chemother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1016\/j.bmc.2012.05.025","article-title":"Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles","volume":"20","author":"Holler","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4014\/jmb.1302.02045","article-title":"Antibacterial effect of amentoflavone and its synergistic effect with antibiotics","volume":"23","author":"Hwang","year":"2013","journal-title":"J. Microbiol. Biotechnol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/jac\/dks232","article-title":"Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus","volume":"67","author":"Kalia","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e00951","DOI":"10.1128\/Spectrum.00951-21","article-title":"Repurposing approved drugs as fluoroquinolone potentiators to overcome efflux pump resistance in Staphylococcus aureus","volume":"9","author":"Mahey","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"40239","DOI":"10.1038\/s41598-025-24167-5","article-title":"Evaluating the ciprofloxacin potentiation efficacy of repurposed drug flupentixol through efflux pump inhibition of pathogenic bacteria","volume":"15","author":"Momin-Reza","year":"2025","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/s41467-020-17735-y","article-title":"Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates","volume":"11","author":"Papkou","year":"2020","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41579-025-01226-2","article-title":"Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment","volume":"24","author":"Parsons","year":"2026","journal-title":"Nat. Rev. Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1128\/AAC.01058-10","article-title":"Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus","volume":"54","author":"Patel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/antibiotics12071168","article-title":"Resveratrol as an inhibitor of the NorA efflux pump and resistance modulator in Staphylococcus aureus","volume":"12","author":"Santos","year":"2023","journal-title":"Antibiotics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3389\/fmicb.2017.01868","article-title":"Boeravinone B, a novel dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and human P-glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria","volume":"8","author":"Singh","year":"2017","journal-title":"Front. Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17394","DOI":"10.1038\/s41598-023-43038-5","article-title":"Inhibition of the norA gene expression and the NorA efflux pump by the tannic acid","volume":"13","author":"Tintino","year":"2023","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.3390\/molecules26226904","article-title":"Flavonoids as inhibitors of bacterial efflux pumps","volume":"26","author":"Waditzer","year":"2021","journal-title":"Molecules."},{"key":"B25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jep.2017.08.040","article-title":"Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: a review","volume":"210","author":"Wang","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41467-024-54986-5","article-title":"A fiducial-assisted strategy compatible with resolving small MFS transporter structures in multiple conformations using cryo-EM","volume":"16","author":"Xie","year":"2025","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"bbac087","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein\u2013ligand docking by template fitting","volume":"23","author":"Yang","year":"2022","journal-title":"Brief. Bioinform."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1919329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:43:56Z","timestamp":1788417836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1919329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":27,"alternative-id":["10.3389\/fmicb.2026.1919329"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1919329","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1919329"}}